Apheresis is a medical procedure that involves removing specific components from a patient’s blood and returning the remaining blood components to the patient’s circulation. The process utilizes a specialized machine called an apheresis machine or apheresis device, which separates blood into its individual components, such as red blood cells, white blood cells, platelets, plasma, or specific blood proteins.

Plasmapheresis involves removing plasma from the patient’s blood, which contains antibodies, proteins, and other soluble factors. This procedure is commonly used to treat autoimmune disorders, neurological diseases, and certain hematological conditions by removing harmful antibodies or toxins from the bloodstream. Apheresis procedures contribute to the supply of blood products, including plasma, platelets, and red blood cells, which are essential for various medical treatments and transfusion therapies. As the demand for blood products increases due to factors such as population growth, aging demographics, and advances in medical care, there is a corresponding need for apheresis procedures to collect and process these products. Apheresis centers play a critical role in maintaining adequate supplies of blood components to meet patient needs and support healthcare delivery. In terms of revenue, the global apheresis market was worth US$ 2.48 Bn in 2023, anticipated to witness CAGR of 8.2% during 2024 – 2034.

Trends in the Global Apheresis Market

• Increasing Demand for Therapeutic Apheresis: There is a growing demand for therapeutic apheresis procedures to treat a wide range of medical conditions, including autoimmune diseases, hematologic disorders, neurological disorders, and solid organ transplant complications. Therapeutic apheresis is increasingly recognized as an effective treatment modality for removing pathogenic substances, disease-causing factors, or aberrant cells from the bloodstream, offering targeted therapeutic interventions with favorable outcomes for patients.
• Rising Incidence of Chronic Diseases: The increasing prevalence of chronic diseases such as autoimmune disorders, hematologic malignancies, renal diseases, and neurological disorders is driving the demand for apheresis procedures globally. As the burden of chronic diseases continues to rise due to factors such as aging populations, lifestyle changes, and environmental factors, there is a corresponding need for advanced therapies like apheresis to manage disease symptoms, improve patient outcomes, and enhance quality of life.
• Growing Focus on Regenerative Medicine: Apheresis plays a crucial role in regenerative medicine applications, particularly in stem cell collection and processing for hematopoietic stem cell transplantation (HSCT) and cell-based therapies. The growing interest in regenerative medicine and cell-based therapies for treating various diseases and injuries has spurred demand for apheresis procedures to obtain high-quality stem cells, immune cells, or progenitor cells for therapeutic purposes. Apheresis centers are increasingly recognized as key players in supporting regenerative medicine initiatives and advancing cell-based therapies.

Global Apheresis Market Revenue & Forecast, (US$ Million), 2016 – 2034

Apheresis device has garnered major market share in the global apheresis market during the forecast period.  An apheresis device is a medical instrument designed to perform apheresis, a therapeutic procedure that involves the separation and extraction of specific components from a patient’s blood. These devices are sophisticated machines equipped with various components and mechanisms to facilitate the safe and efficient removal or collection of blood components. Apheresis devices are equipped with ports or catheters that allow access to the patient’s bloodstream. These ports are typically connected to the patient’s veins through venous catheters or vascular access devices, providing a means for withdrawing blood from the body and returning processed blood components. The growing prevalence of chronic conditions such as autoimmune diseases, hematologic disorders, and neurological diseases drives the demand for apheresis procedures. Conditions like multiple sclerosis, myasthenia gravis, and thrombotic thrombocytopenic purpura often require apheresis to remove harmful antibodies, abnormal blood cells, or disease-causing factors from the bloodstream, leading to increased demand for apheresis devices.

Plasmapheresis application had the highest share in the global apheresis market in 2023.

Plasmapheresis is widely used in the treatment of autoimmune disorders, including Guillain-Barré syndrome, myasthenia gravis, systemic lupus erythematosus (SLE), and autoimmune hemolytic anemia. In these conditions, the immune system produces antibodies that attack healthy tissues or cells, leading to inflammation and tissue damage. Plasmapheresis helps remove circulating antibodies and immune complexes from the bloodstream, reducing disease severity and improving patient outcomes. Plasmapheresis is effective in managing various neurological conditions, such as chronic inflammatory demyelinating polyneuropathy (CIDP), multiple sclerosis (MS), and neuromyelitis optica spectrum disorder (NMOSD). By removing pathogenic antibodies and inflammatory mediators from the bloodstream, plasmapheresis helps reduce inflammation, prevent nerve damage, and alleviate neurological symptoms, leading to improved quality of life for patients.

By end user blood collection centers and blood component providers segment had the highest share in the global apheresis market in 2023.

The demand for blood and blood components is closely tied to the number of medical procedures and surgeries performed. Surgical interventions, trauma care, cancer treatments, organ transplants, and childbirth are some of the medical situations that may require blood transfusions or blood products. As the population grows and ages, the demand for medical procedures increases, driving the need for blood collection centers to supply adequate blood products. Through the collection, processing, and distribution of blood products to meet the needs of patients undergoing various medical treatments, surgeries, and transfusions, blood collection centers and blood component providers play a crucial role in the healthcare ecosystem. These facilities need cutting-edge apheresis technologies to effectively collect and separate blood components from whole blood donations as the demand for blood components like plasma, platelets, and red blood cells continuously growing.

By region North America dominated the global apheresis market in 2023.

North America is at the forefront of technological innovation in apheresis procedures. Apheresis procedures are integral to the field of transplantation and immunotherapy in North America. Apheresis is used to collect hematopoietic stem cells for autologous and allogeneic stem cell transplantation, as well as to remove donor-specific antibodies or pathogenic immune cells in the context of solid organ transplantation and hematopoietic stem cell transplantation (HSCT). Apheresis plays a crucial role in mitigating transplant-related complications, promoting graft acceptance, and improving long-term transplant outcomes. The demand for apheresis procedures in North America is driven by the need to effectively manage autoimmune, neurological, hematologic, and transplant-related disorders, as well as the availability of clinical guidelines, advancements in apheresis technology, and evidence-based practice recommendations. As healthcare providers recognize the clinical benefits of apheresis and patients seek alternative treatment options for complex medical conditions, the demand for apheresis procedures is expected to continue to grow in North America.

Competitive Landscape

Some of the players operating in the apheresis market are

• Asahi Kasei Medical Co. Ltd.
• Baxter International
• Cerus Corporation
• Fresenius Medical Care
• Haemonetics Corporation
• HemaCare Corporation
• Kaneka Corporation
• Kawasumi Laboratories Inc.
• Macopharma SA
• Nikkiso Co.Ltd.
• Otsuka Holdings Co. Ltd
• Terumo BCT Inc.
• Other Industry Participants

Global Apheresis Market Scope

 Global Apheresis Market

By Product

• Apheresis disposables
• Apheresis devices
  • Centrifugal apheresis devices
  • Membrane separators

By Procedure

• Automated blood collection
• Therapeutic apheresis
  • Therapeutic apheresis disposables
    • Neurological disorders
    • Blood disorders
    • Renal disorders
    • Autoimmune disorders
    • Metabolic disorders
    • Cardiovascular disorders
    • Other disorders
  • Therapeutic apheresis devices

By Technology

• Centrifugation
  • Continuous flow centrifugation
  • Intermittent flow centrifugation
• Membrane separation

By Application

• Plasmapheresis
• plateletpheresis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• Other applications

By End User

• Blood collection centers and blood component providers
• Hospitals and transfusion centers
• Other end users

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

 Report Layout

Table of Contents

.

.

Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion.

.

**Exclusive for Multi-User and Enterprise User.

Global Apheresis Market

By Product

• Apheresis disposables
• Apheresis devices
  • Centrifugal apheresis devices
  • Membrane separators

By Procedure

• Automated blood collection
• Therapeutic apheresis
  • Therapeutic apheresis disposables
    • Neurological disorders
    • Blood disorders
    • Renal disorders
    • Autoimmune disorders
    • Metabolic disorders
    • Cardiovascular disorders
    • Other disorders
  • Therapeutic apheresis devices

By Technology

• Centrifugation
  • Continuous flow centrifugation
  • Intermittent flow centrifugation
• Membrane separation

By Application

• Plasmapheresis
• plateletpheresis
• Erythrocytapheresis
• Leukapheresis
• Photopheresis
• Other applications

By End User

• Blood collection centers and blood component providers
• Hospitals and transfusion centers
• Other end users

By Region

• North America (U.S., Canada, Mexico, Rest of North America)
• Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe)
• Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
• Latin America (Brazil, Argentina, Rest of Latin America)

The Niche Research approach encompasses both primary and secondary research methods to provide comprehensive insights. While primary research is the cornerstone of our studies, we also incorporate secondary research sources such as company annual reports, premium industry databases, press releases, industry journals, and white papers.

Within our primary research, we actively engage with various industry stakeholders, conducting paid interviews and surveys. Our meticulous analysis extends to every market participant in major countries, allowing us to thoroughly examine their portfolios, calculate market shares, and segment revenues.

Our data collection primarily focuses on individual countries within our research scope, enabling us to estimate regional market sizes. Typically, we employ a bottom-up approach, meticulously tracking trends in different countries. We analyze growth drivers, constraints, technological innovations, and opportunities for each country, ultimately arriving at regional figures.Our process begins by examining the growth prospects of each country. Building upon these insights, we project growth and trends for the entire region. Finally, we utilize our proprietary model to refine estimations and forecasts.

Our data validation standards are integral to ensuring the reliability and accuracy of our research findings. Here’s a breakdown of our data validation processes and the stakeholders we engage with during our primary research:

• Supply Side Analysis: We initiate a supply side analysis by directly contacting market participants, through telephonic interviews and questionnaires containing both open-ended and close-ended questions. We gather information on their portfolios, segment revenues, developments, and growth strategies.
• Demand Side Analysis: To gain insights into adoption trends and consumer preferences, we reach out to target customers and users (non-vendors). This information forms a vital part of the qualitative analysis section of our reports, covering market dynamics, adoption trends, consumer behavior, spending patterns, and other related aspects.
• Consultant Insights: We tap into the expertise of our partner consultants from around the world to obtain their unique viewpoints and perspectives. Their insights contribute to a well-rounded understanding of the markets under investigation.
• In-House Validation: To ensure data accuracy and reliability, we conduct cross-validation of data points and information through our in-house team of consultants and utilize advanced data modeling tools for thorough verification.

The forecasts we provide are based on a comprehensive assessment of various factors, including:

• Market Trends and Past Performance (Last Five Years): We accurately analyze market trends and performance data from preceding five years to identify historical patterns and understand the market’s evolution.
• Historical Performance and Growth of Market Participants: We assess the historical performance and growth trajectories of key market participants. This analysis provides insights into the competitive landscape and individual company strategies.
• Market Determinants Impact Analysis (Next Eight Years): We conduct a rigorous analysis of the factors that are projected to influence the market over the next eight years. This includes assessing both internal and external determinants that can shape market dynamics.
• Drivers and Challenges for the Forecast Period:Identify the factors expected to drive market growth during the forecast period, as well as the challenges that the industry may face. This analysis aids in deriving an accurate growth rate projection.
• New Acquisitions, Collaborations, or Partnerships: We keep a close watch on any new acquisitions, collaborations, or partnerships within the industry. These developments can have a significant impact on market dynamics and competitiveness.
• Macro and Micro Factors Analysis:A thorough examination of both macro-level factors (e.g., economic trends, regulatory changes) and micro-level factors (e.g., technological advancements, consumer preferences) that may influence the market during the forecast period.
• End-User Sentiment Analysis: To understand the market from the end-user perspective, we conduct sentiment analysis. This involves assessing the sentiment, preferences, and feedback of the end-users, which can provide valuable insights into market trends.
• Perspective of Primary Participants: Insights gathered directly from primary research participants play a crucial role in shaping our forecasts. Their perspectives and experiences provide valuable qualitative data.
• Year-on-Year Growth Trend: We utilize a year-on-year growth trend based on historical market growth and expected future trends. This helps in formulating our growth projections, aligning them with the market’s historical performance.

Research process adopted by TNR involves multiple stages, including data collection, validation, quality checks, and presentation. It’s crucial that the data and information we provide add value to your existing market understanding and expertise. We have also established partnerships with business consulting, research, and survey organizations across regions and globally to collaborate on regional analysis and data validation, ensuring the highest level of accuracy and reliability in our reports.